This no-fee CME webinar provides valuable information on the efficacy, safety, indications, optimal patient selection, and surgical pearls for microinvasive glaucoma surgery (MIGS).
Supported through an educational grant from New World Medical.Targeting the Trabecular Meshwork: Goniotomy Past, Present, and Future
Learning Objectives
At the completion of this educational activity, the participating ophthalmologist will be better able to: •Identify and understand the advantages and disadvantages of trabecular, supraciliary, and subconjunctival microinvasive glaucoma surgery (MIGS) procedures. •Describe the efficacy and safety of trabecular meshwork (TM) and Schlemm canal MIGS procedures. •Identify the patient characteristics that favor the use of TM and Schlemm canal MIGS procedures. •Adopt optimal surgical techniques when performing TM and Schlemm canal MIGS procedures. Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.Jason Bacharach, MD
Founding Partner & Director of ResearchNorth Bay Eye Associates Inc.Sonoma County, California
Co-Director of Glaucoma DivisionCalifornia Pacific Medical CenterSan Francisco, CaliforniaJella An, MD
Medical Director, University Eye Institute EastDirector, Glaucoma Service and Fellowship ProgramDepartment of OphthalmologyUniversity of MissouriColumbia, Missouri
Jason Bacharach, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Glaukos and New World Medical. Speaker’s Bureau: Alcon, Allergan, Glaukos, and New World Medical. Grant/Research Support: Allergan, Glaukos, and Santen. Jella An, MD, and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Iridex, New World Medical. Grant/Research: New World Medical. EDITORIAL SUPPORT •Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests. •Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests. •Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests. •Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!





















